Variable parathyroid hormone(1-84)/carboxyl-terminal PTH ratios detected by 4 novel parathyroid hormone assays

Clinical Nephrology

Volumn 61, Issue 5, 2004, Pages 337-343

  Koller, H ^a   Zitt, E ^a,b   Staudacher, G ^a   Neyer, U ^b   Mayer, G ^a   Rosenkranz, Alexander R ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Landeskrankenhaus Feldkirch   (Austria)

Author keywords

Parathormone; PTH assay; PTH(1 84) C PTH ratio; Renal osteodystrophy

Indexed keywords

PARATHYROID HORMONE; PARATHYROID HORMONE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CHEMOLUMINESCENCE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC KIT; FEMALE; HORMONE DETERMINATION; HUMAN; IMMUNORADIOMETRIC ASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; QUANTITATIVE ANALYSIS; RENAL OSTEODYSTROPHY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

EID: 2342457029     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP61337     Document Type: Article

References (22)

1. Coen G, Bonucci E, Ballanti P, Balducci A, Calabria S, Nicolai GA, Fischer MS, Lifrieri F, Manni M, Morosetti M, Moscaritolo E, Sardella D 2002 PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40: 348-354
2. Divieti P, John MR, Juppner H, Bringhurst FR 2002 Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology 143: 171-176
3. Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor TL 2001 Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16: 605-614
4. Goodman WG, Juppner H, Salusky IB, Sherrard DJ 2003 Parathyroid hormone (PTH), PTH-derived peptides and new PTH assays in renal osteodystrophy. Kidney Int 63: 1-11
5. Goodman WG, Salusky IB, Juppner H 2002 New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments. Nephrol Dial Transplant 17: 1731-1736
6. John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Juppner H 1999 A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84: 4287-4290
7. Langub MC, Monier-Faugere MC, Wang G, Williams JP, Koszewski NJ, Malluche HH 2003 Administration of PTH(7-84) antagonizes the effects of PTH(1-84) on bone in rats with moderate renal failure. Endocrinology 144: 1135-1138
8. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D'Amour P 1998 A non(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44: 805-809
9. Malluche H, Faugere MC 1990 Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 38: 193-211
10. Malluche HH 1995 Renal bone disease - an ongoing challenge to the nephrologist. Clin Nephrol 44 (Suppl 1): S38-41
11. Malluche HH, Mawad H, Trueba D, Monier-Faugere MC 2003 Parathyroid hormone assays - evolution and revolutions in the care of dialysis patients. Clin Nephrol 59: 313-318
12. Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH 2001 Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 60: 1460-1468
13. Nakanishi S, Kazama JJ, Shigematsu T, Iwasaki Y, Cantor TL, Kurosawa T, Fukagawa M 2001 Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients. Am J Kidney Dis 38: S172-174
14. Nguyen-Yamamoto L, Rousseau L, Brossard JH, Lepage R, D'Amour P 2001 Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor. Endocrinology 142: 1386-1392
15. Nguyen-Yamamoto L, Rousseau L, Brossard JH, Lepage R, Gao P, Cantor T, D'Amour P 2002 Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays. Eur J Endocrinol 147: 123-131
16. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts JT Jr, Segre GV 1987 Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33: 1364-1367
17. Reichel H, Esser A, Roth HJ, Schmidt-Gayk H 2003 Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 18: 759-768
18. Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Juppner H 2003 Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 63: 1801-1808
19. Segre GV, Tregear GW, Potts JT Jr 1975 Development and application of sequence-specific radioimmunoassays for analysis of the metabolism of parathyroid hormone. Methods Enzymol 37: 38-66
20. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A 2000 A novel mechanism for skeletal resistance in uremia. Kidney Int 58: 753-761
21. Terry AH, Orrock J, Meikle AW 2003 Comparison of 2 Third-Generation Parathyroid Hormone Assays. Clin Chem 49: 336-337
22. Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y 1995 Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26: 836-844